GE Vernova (GEV)
NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
Reading GEV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GEV free→NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
Reading GEV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GEV free→QuarterlyIQ Insights · GEV
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. Current price $1077.50. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $1,078 the market pays 58× p/e — above the 31× p/e peer median but in line with its own 58× history. That premium reflects a durable franchise our peer-anchored $905 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $1,080–$1,400. Note: our $905 fair value sits below the entire analyst range ($1,080–$1,400). Not investment advice.
$1080.00 – $1400.00 (median $1250.00) · 17 analysts · as of 2026-06-16
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 1280% over what the business is worth with no growth; closing that gap needs roughly 24.4 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $6.53/sh owner earnings.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $1250.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $679.72 | — | — | Analyst | high |
| dcf fcff | 12M | $711.95 | — | — | Analyst | high |
| graham number | 12M | $151.51 | — | — | TTM | high |
| Peer P/FCF | 12M | $776.82 | 28.1 | 27.67 | TTM | high |
| Peer P/E | 12M | $575.63 | 31.3 | 18.42 | TTM | high |
| Peer P/S | 12M | $511.55 | 3.5 | 144.76 | TTM | high |
| PEG | 12M | $805.57 | 43.7 | 18.42 | TTM | high |
| Own P/E history | 12M | $1077.50 | 58.5 | 18.42 | TTM | high |
| triangulated | 12M | $615.17 | 31.3 | 19.69 | Triangulated | high |
| Peer P/E | 3Y | $875.46 | 31.3 | 28.01 | Analyst | medium |
| Peer P/S | 3Y | $833.48 | 3.5 | 235.86 | guidance | medium |
| PEG | 3Y | $1225.18 | 43.7 | 28.01 | Analyst | medium |
| Own P/E history | 3Y | $1638.74 | 58.5 | 28.01 | Analyst | medium |
| Peer P/E | 5Y | $1157.79 | 31.3 | 37.05 | Analyst | high |
| Peer P/S | 5Y | $1088.62 | 3.5 | 308.06 | guidance | high |
| PEG | 5Y | $1620.30 | 43.7 | 37.05 | Analyst | high |
| Own P/E history | 5Y | $2167.24 | 58.5 | 37.05 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.